Scinai Immunotherapeutics... (SCNI)
NASDAQ: SCNI
· Real-Time Price · USD
1.73
0.20 (12.70%)
At close: Aug 21, 2025, 3:59 PM
1.67
-3.43%
After-hours: Aug 21, 2025, 06:10 PM EDT
Scinai Immunotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.68M | -3.7M | -5.14M | -6.5M | -4.7M | -6.76M | -5.98M | -4.94M | -3.22M | -7.07M | -7.76M | -7.73M | -13.31M | 5.63M | -2.8M |
Depreciation & Amortization | 1.23M | 880.1K | 532.91K | 514.91K | 430K | 285K | 283K | 279K | 164.53K | 353.77K | 393.93K | 440.86K | 743.88K | 737.35K | 726.22K |
Stock-Based Compensation | 931K | 1.02M | 1.08M | 1.14M | 2.29M | 2.05M | 2.24M | 2.47M | 1.52M | 2.3M | 2.71M | 2.66M | 2.43M | 2.99M | 3.16M |
Other Working Capital | 3.91M | 3.14M | 5.69M | 2.98M | -1.18M | -359.71K | -3.47M | -438K | 242.9K | 60.47K | 608.83K | 646.66K | -5.62K | 375.59K | 576.39K |
Other Non-Cash Items | -16.02M | -7.7M | -9.77M | -7.22M | -4.91M | -1.17M | 173.03K | -2.26M | -5.38M | -4.62M | -3.01M | -3.22M | -755.25K | -21.22M | -14.54M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.69M | 2.83M | 5.51M | 2.69M | -1.27M | -352K | -3.44M | -323K | 497.92K | 684.33K | 568.71K | 699.77K | 444.47K | 321.69K | 926.95K |
Operating Cash Flow | -6.48M | -6.67M | -7.79M | -9.38M | -8.16M | -5.93M | -6.72M | -4.77M | -6.42M | -8.34M | -7.1M | -7.15M | -10.45M | -11.54M | -12.53M |
Capital Expenditures | -246.01K | -262.01K | -633K | -637K | -403K | -383K | 29K | -486K | -578.28K | -579.7K | -647.21K | -132.79K | -70.69K | -1.05M | -1.39M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 494.65 | 494.65 | 494.65 |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.68K | -11.47K | -11.78K | -714.18 | 137.52K | 140.31K | 142.93K |
Investing Cash Flow | -246K | -262K | -633K | -637K | -403K | -383K | 29K | -486K | -591.24K | -595.27K | -663.09K | -137.6K | 67.51K | -905.69K | -1.25M |
Debt Repayment | n/a | -2.97K | -2.97K | -2.97K | -2.97K | n/a | n/a | n/a | n/a | -95.22K | -192.44K | -283.96K | -381.03K | -375.13K | -367.37K |
Common Stock Repurchased | -947K | -947K | -947K | -947K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.39M | 3.47M | 3.46M | 2.04M | 1.1M | 6.93K | 6.93K | n/a | 8.4M | 8.19M | 8.19M | 20.79M | 12.39M | 12.65M | 15.63M |
Financial Cash Flow | 1.44M | 2.52M | 2.51M | 1.09M | 1.09M | 6.93K | 6.93K | n/a | 8.4M | 8.1M | 8M | 20.51M | 12.01M | 12.27M | 15.27M |
Net Cash Flow | -5.32M | -4.42M | -5.96M | 5.01M | 6.48M | -3.79M | -4.61M | -17.52M | -10.75M | -809.17K | 1M | 14.59M | 3.52M | 1.05M | 2.55M |
Free Cash Flow | -6.73M | -6.93M | -8.42M | -10.02M | -8.56M | -6.32M | -6.7M | -5.26M | -7M | -8.92M | -7.75M | -7.29M | -10.52M | -12.59M | -13.92M |